GlassScriptPhysician profile
Rahul S Gupta
NPI 1184835159
$1,850.59
in general payments reported to CMS, 2019-2025
12 companies · $1,137 in 2025
The $1,137 reported for 2025 was more than what 94% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.15 · 2020: $11.78 · 2021: $89.85 · 2023: $276 · 2024: $281 · 2025: $1,137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $942 · Travel and Lodging: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $942.46 |
| Travel and Lodging | $752.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $1,129.38 | 2024-2025 | Iovera, Exparel |
| Fisher & Paykel Healthcare INC | $158.30 | 2023-2025 | Fisher & Paykel Healthcare |
| Heron Therapeutics, INC. | $136.31 | 2021-2024 | Aponvie, Zynrelef |
| Edwards Lifesciences Corporation | $123.80 | 2019-2023 | Hemosphere |
| Medtronic, INC. | $95.71 | 2024-2025 | Bis, Mcgrath Mac |
| Vertex Pharmaceuticals Incorporated | $58.09 | 2025 | |
| Mindray Ds USA, INC. | $49.94 | 2025 | A7 Anesthesia System |
| Mallinckrodt Enterprises LLC | $35.06 | 2019 | |
| Becton, Dickinson and Company | $22.58 | 2024 | Hemosphere |
| Cardiva Medical, INC. | $16.67 | 2023 | Cardiva Vascade 6/7f Vcs |
| Cumberland Pharmaceuticals, INC. | $12.97 | 2023 | Caldolor |
| Mallinckrodt Hospital Products INC. | $11.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.